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Abstract
Objective: To improve the characterization of asymptomatic subjects with brain magnetic resonance imaging (MRI)
abnormalities highly suggestive of multiple sclerosis (MS), a condition named as ‘‘radiologically isolated syndrome’’ (RIS).
Methods: Quantitative MRI metrics such as brain volumes and magnetization transfer (MT) were assessed in 19 subjects
previously classified as RIS, 20 demographically-matched relapsing-remitting MS (RRMS) patients and 20 healthy controls
(HC). Specific measures were: white matter (WM) lesion volumes (LV), total and regional brain volumes, and MT ratio (MTr) in
lesions, normal-appearing WM (NAWM) and cortex.
Results: LV was similar in RIS and RRMS, without differences in distribution and frequency at lesion mapping. Brain volumes
were similarly lower in RRMS and RIS than in HC (p,0.001). Lesional-MTr was lower in RRMS than in RIS (p = 0.048); NAWM-
MTr and cortical-MTr were similar in RIS and HC and lower (p,0.01) in RRMS. These values were particularly lower in RRMS
than in RIS in the sensorimotor and memory networks. A multivariate logistic regression analysis showed that 13/19 RIS had
$70% probability of being classified as RRMS on the basis of their brain volume and lesional-MTr values.
Conclusions: Macroscopic brain damage was similar in RIS and RRMS. However, the subtle tissue damage detected by MTr
was milder in RIS than in RRMS in clinically relevant brain regions, suggesting an explanation for the lack of clinical
manifestations of subjects with RIS. This new approach could be useful for narrowing down the RIS individuals with a high
risk of progression to MS.
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Introduction
Over the past decade, the increasing use of magnetic resonance
imaging (MRI) in the diagnostic work-up of pathological
conditions has contributed to the uncovering of asymptomatic
brain pathologies [1,2]. Incidental MRI findings are relatively
common in the brains of asymptomatic subjects, increasing with
age and the use of high-resolution MRI sequences [1].
Recently, a number of studies have specifically focused on
subjects who reveal unanticipated brain spatial dissemination of
MRI lesions highly suggestive of multiple sclerosis (MS) in the
absence of a clinical scenario [3,4,5,6], a condition named as
‘‘radiologically isolated syndrome’’ (RIS) [5].
Much effort has been devoted to attempting to correctly identify
and predict the clinical evolution of RIS subjects, in view of the
growing consensus for an early disease-modifying treatment in
patients diagnosed with MS [7,8]. Two recent works suggest that
the presence of contrast-enhancing and spinal cord lesions increase
the risk of disease progression [5,6]. Currently, however, the
natural course of RIS is largely unknown, with the impossibility of
clarifying whether the observed changes reflect the earliest form of
MS or something else, including a non-disabling form of MS [9].
In line with this, it would be very important to have a better
characterization of the brain damage as detected by MRI,
occurring in these subjects, thus possibly providing potential
predictors of disease progression.
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Quantitative MR indices of brain tissue damage such as brain
volumes, magnetization transfer (MT) imaging or other patholog-
ically specific MR measures have been largely used in MS and in
several other neurological disorders at their early clinical stages
and even in the absence of relevant clinical symptoms [10,11,12].
Since these MR indices can ensure an accurate assessment of the
damage occurring in both lesions and normal-appearing brain
regions [13], we measured them in RIS subjects as well as in
healthy controls (HC) and relapsing-remitting (RR) MS patients
with the aims of i) providing a tissue-specific characterization of
the brain damage occurring in RIS, ii) assessing whether their
quantitative brain tissue measures share differences or similarities
with those of HC and RRMS patients, and iii) determining
whether one or more of these measures can be helpful for a better
classification of these asymptomatic subjects.
Methods
Study population
Nineteen asymptomatic subjects (14 females, 5 males, age: mean
37 years, range 19–51 years) were enrolled in the study. All
fulfilled the recently identified criteria for RIS [5], which imply
that none of the subjects had previously experienced remitting
clinical symptoms consistent with neurologic dysfunction of the
central nervous system (CNS). They were all consecutively
contacted by the same neurologist (MLS) who followed an
identical procedure to avoid potential sampling bias. Table 1
summarizes the demographic and clinical characteristics of the
subjects, including the reason for the first MRI, which was
performed a mean of 2.41 (range 0.10–6.96) years before. At that
time, 15/19 RIS subjects had also performed cervical spine MRI
and CSF assessment (Table 1). All subjects agreed to participate in
the study, which included an MR examination (without injection
of contrast agent) and a full neurological examination, which was
independently performed by two raters (MLS and FR) to further
exclude signs of CNS dysfunction. Sixteen out of 19 subjects also
underwent neuropsychological testing through the Rao Brief
Repeatable Battery (BRB) [14]. The MR examinations of the RIS
subjects were compared to those of 20 demographically-matched
patients with a diagnosis of RRMS according to revised
McDonald’s criteria [15] (13 females, 7 males, age: mean 37
years, range 24–50 years) and HC (12 females, 8 males, age: mean
37 years, range 22–51 years). To be included in the study, RRMS
patients had to be free from relapse and steroid treatment for at
least 3 months. They had a relatively early disease stage (disease
duration: mean 4.1 years, range 1.0–7.3 years) and mild disability
(Expanded Disability Status Scale [EDSS]: median 1.5, range 1.0–
5.0). The HC were recruited from laboratory and hospital workers
and were included in the group if they had normal neurological
examination and no history of neurological disorders.
The study received approval from the Ethics Committee of the
Faculty of Medicine of the University of Siena and informed
written consent was obtained from all study subjects.
MRI examination
All subjects were examined at the MR center of the University
of Siena using an identical MR protocol. Acquisitions of brain
MRI were obtained in a single session using a Philips Gyroscan
operating at 1.5 T (Philips Medical Systems, Best, The Nether-
lands). A sagittal survey image was used to identify the anterior
commissure (AC) and posterior commissure (PC). A dual-echo,
turbo spin-echo sequence (TR/TE1/TE2= 2075/30/90 ms,
2566256 matrix, 1 signal average, 250 mm field of view [FOV],
50 contiguous 3 mm slices) yielding proton density (PD) and
T2-weighted (T2-W) images was acquired in the axial plane
parallel to the AC-PC line. Subsequently, an MT sequence was
performed acquiring two axial T1-weighted (T1-W) gradient echo
images, one without and one with MT saturation pulses (TR/
TE=35/10 ms, 2566256 matrix, 1 signal average, 250 mm
FOV). This sequence yielded image volumes of 50 slices, 3 mm
thick, oriented to exactly match the PD/T2-W sequence.
Monthly quality assurance sessions were carried out and no
major hardware upgrades were done on the scanner during the
time of the study.
MR data analysis
Lesions. For each RIS and RRMS subject, MR scans were
first visually assessed by a single observer (FR) who was unaware of
subject identity. Labelling of T2-W and T1-W lesion volume (LV)
was then performed by employing a semiautomated segmentation
technique based on user-supervised local thresholding (Jim 4.0,
Xinapse System, Leicester, UK). For the T2-W LV classification,
lesion borders were determined primarily on PD images.
Information from T2-W and T1-W images was also considered.
T1-W hypointense WM lesions were defined as those lesions with
signal intensity between that of the grey matter (GM) and the
cerebrospinal fluid (CSF) on T1-W scans [16]. The value of both
T2-W and T1-W total brain LV was calculated by multiplying
lesion area by slice thickness.
Standard-space T2-W and T1-W lesion probability maps
(LPMs) of the RRMS and RIS groups were created by using
FSL tools (part of FSL 4.1- http://www.fmrib.ox.ac.uk/fsl/[17])
and following these sequential steps, as previously described [18]:
i) binary lesion masks were produced from individual T2-W and
T1-W lesion contours; ii) each patient’s T1-W image was registered
to the MNI152 template using a fully affine transformation (12
parameters) and the resulting transformed images were averaged
to obtain a study-specific T1-W template; iii) each patient’s PD
image was registered to the corresponding T1-W image using a
rigid body transformation and trilinear interpolation; iv) the
transformation parameters were applied to the T2-W lesion masks,
bringing them into alignment with the individual T1-W images; v)
each patient’s T1-W image was then registered to the T1-W
template, using a nonlinear registration, and the resulting
transformation parameters were applied to the T2-W and T1-W
lesion masks which had been previously registered onto the
individual T1-W images, using trilinear interpolation. In order to
maintain the volume of the transformed lesion masks as closely as
possible to those in the native brain images after the trilinear
interpolation, the lesion masks were thresholded using a value of
0.5; two observers independently checked all the co-registered
lesions masks; vi) T2-W and T1-W LPMs were generated by
averaging the T2-W and T1-W lesion masks, at each voxel, in
standard space. For each map, the resulting voxel intensity
indicates the probability of lesion occurrence for that voxel.
Brain Volume. Brain parenchyma volumes were measured
on T1-W images by using the cross-sectional version of the SIENA
software, SIENAX [19,20], part of FSL. SIENAX allows global
measures of normalized brain volume (NBV) as well as, after
tissue-class segmentation, selective measurements of normalized
cortical volume (NCV) and normalized WM volume (NWMV)
[21]. Reproducibility tests have resulted in a mean standard error
across a group of normal subjects of about 0.5–1% [19]. To avoid
tissue misclassification due to WM lesions, the latter were masked
out and refilled with intensities matching the surrounding normal-
appearing WM (NAWM) before each tissue-class segmentation
analysis [22].
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MT. For the analysis of MT data, we used a fully automated
procedure previously described [23]. Briefly, saturated (Sat)
images were registered to non-saturated (No-Sat) images [17].
The brain was extracted from both Sat and No-Sat images [17]
and MT ratio (MTr) images were then calculated using the
formula MTr= 100*(No-Sat – Sat)/No-Sat [24]. Mean values of
MTr were assessed for the whole brain (WB-MTr) and for
different tissue types, produced by using an automated
segmentation method [17] to obtain lesional-MTr, ‘non-
adjacent-to-lesions’ NAWM MTr and cortical-MTr [23].
Finally, a voxel-based analysis of MTr across the whole brain
was performed as previously described [23,25]. To test for
differences in LPM and WB-MTr between the RIS and RRMS
groups (unpaired t-test), we used the randomise program within FSL
to carry out permutation-based testing. Clusters were formed
according to a defined threshold (t.3) and corrected for multiple
comparisons (across space) by building up the null distribution of
the maximum cluster size (for each permutation). Results were
considered significant at the 0.05 level. Anatomical locations of the
significant GM and WM clusters of MTr analysis were determined
by reference to the Harvard-Oxford atlas and to a diffusion tensor
imaging (DTI)-based atlas of human WM anatomy, both
integrated into FSLView, also part of FSL.
General statistics
The unpaired t-test was used for comparing RIS subjects and
RRMS patients and for comparing RIS subjects with and without
DIT. Differences between RIS, RRMS and HC groups were
assessed by using analysis of variance (ANOVA) followed by
pairwise post-hoc comparisons using Tukey’s HSD procedure to
account for multiple comparisons. Data were considered signifi-
cant at the 0.05 level. In addition, a univariate logistic regression
model was used to screen the ability of each MRI volumetric (i.e.,
NBV, NWMV and NCV) and MTr (i.e, WB-MTr, NAWM-MTr,
cortical-MTr and lesional-MTr) variable to separate RRMS
patients and HC. The most significant volumetric and MTr
variable, as estimated by this univariate analysis on RRMS
patients and HC, were included into a penalized multivariate
logistic regression model. The probability of each RIS subject to
be HC or RRMS was estimated according to the following
procedure:
a) an individual patient score was calculated using the
coefficients estimated by the penalized logistic regression:
a)
score~c{V1  x{MTr1  y
where c was the constant of the model, V1 was the most
significant volumetric variable and x its estimated coefficient;
MTr1 was the most significant MTr variable and y its
estimated coefficient.
b) the probability for a RIS subject to be RRMS was then
calculated according to the logistic equation as follows:
Table 1. Demographic and clinical characteristics of subjects with RIS.
Subjects Sex Age
Family historyof
MS
Age at first
brain MRI
Reason for first
brain MRI
Spinal cord
MRI‘
DIT at brain
MRI CSF* VEPs# Cognition$
1 M 45 No 44 Depression 2 2 2 2 +
2 F 51 No 50 Cervical Trauma + + + + n.p.
3 M 37 No 35 Dermatitis 2 2 2 2 2
4 F 37 No 34 Headache n.p. 2 + 2 2
5 M 43 Yes 42 Neuropathic pain 2 + 2 2 n.p.
6 F 46 Yes 40 MS family history + 2 n.p. 2 +
7 F 23 No 21 Pituitary adenoma + + + n.p. 2
8 F 45 No 39 Cervical trauma + + + 2 +
9 M 31 Yes 29 Headache 2 + 2 n.p. 2
10 F 38 No 31 Migraine with aura 2 + + 2 2
11 F 23 No 22 Migraine without aura + + + + 2
12 M 46 No 45 Headache n.p. 2 n.p. 2 2
13 F 28 No 23 Facial trauma 2 2 n.p. n.p. +
14 F 39 Yes 39 Otosclerosis n.p. 2 n.p. n.p. 2
15 F 19 No 19 Headache + + + + 2
16 F 41 No 40 Dizziness (,2 mins) 2 2 2 2 2
17 F 43 No 43 Anxiety n.p. 2 + 2 2
18 F 34 No 34 Neck pain + + + 2 2
19 F 31 No 28 Obesity 2 + + 2 n.p.
n.p. = not performed.
DIT = dissemination in time.
CSF = cerebrospinal fluid.
See text for other abbreviations.
‘+: presence of cervical spine lesion; -: absence of signal abnormalities.
*+: presence of oligoclonal bands and/or abnormal IgG Index; -: normal pattern.
#+: presence of abnormal P100 in at least one of the eyes; -: normal pattern.
$+: failure of $2 tests at the Rao Brief Repeatable Battery; -: failure of #1 test.
doi:10.1371/journal.pone.0019452.t001
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b)
PRRMS~exp scoreð Þ= 1zexp scoreð Þ½ 
The probability to be HC is 1- PRRMS.
The R software version 2.11 was used to perform all the
statistical analyses.
Results
Clinical and conventional MRI findings
All subjects with RIS had normal neurological examination. At
the BRB, 4/16 of the RIS subjects who performed neuropsycho-
logical tests showed cognitive impairment (Table1). On conven-
tional MRI, the Barkhof criteria were confirmed in all subjects
and, when compared with the previous MRI examination, 10/19
subjects showed at least 1 new T2-W lesion, attesting dissemination
in time (DIT).
Load, distribution and frequency of WM lesions
T2-W LV of the RIS group was similar to that of RRMS (RIS:
6.666.5 cm3, RRMS: 8.469.5 cm3, p = 0.5). There were no
differences in T1-W LV between the two groups (RIS:
3.664.1 cm3, RRMS: 4.565.2 cm3, p = 0.5). In the RIS group,
both T2-W and T1-W LV were higher in subjects with DIT than
in those without DIT (9.367.6 cm3 versus 3.763.5 cm3, p= 0.04
for T2-W LV; 5.664.7 cm
3 versus 1.561.4 cm3, p= 0.02 for T1-
W LV). The LPM analysis (distribution and frequency) of T2-W
(Figure 1) and T1-W lesions did not show differences between RIS
and RRMS (p= 0.10).
Global and tissue-type brain volumes
NBV was similar in RIS and RRMS (1469675 and
1435655 cm3, p = 0.2), lower in both groups than in HC
(1544636 cm3, p,0.0001). NWMV of RIS (779638 cm3) was
not different from that of RRMS (761629 cm3, p = 0.25) and HC
(799621 cm3, p = 0.16), but this measure was lower in RRMS
than in HC (p= 0.002). NCV was comparable in RIS and RRMS
(553642 and 538633 cm3, p = 0.2) and was lower in both groups
than in HC (601624 cm3, p,0.0001). All comparisons are shown
in Figure 2.
Global and tissue-type MTr
WB-MTr was similar in RIS and HC (27.861 and 27.361,
p = 0.30) and higher both in RIS and HC than in RRMS (26.261,
p,0.001 for both). Also, both NAWM-MTr and cortical-MTr
values were similar in RIS and HC (NAWM-MTr: 35.661 and
35.461, p= 0.9; cortical-MTr: 23.560.9 and 23.260.5, p = 0.6),
but were higher in both groups than in RRMS (NAWM-MTr:
34.161, p,0.007 for both comparisons; cortical-MTr: 22.561.5,
p,0.01 for both comparisons). Lesional-MTr values (from T2-W
lesions) were lower in RIS (26.465) and RRMS (23.863) than in
the homologous brain WM areas of HC (35.461; p,0.001), but
were higher (p = 0.048) in RIS than in RRMS. All comparisons
are shown in Figure 3. In the RIS group, lesional-MTr values were
lower in subjects with DIT than in those without DIT (23.763.4
versus 29.364.3, p = 0.006).
At the MTr voxelwise analysis, a number of brain areas showed
lower MTr values in RRMS than in RIS (p,0.05, cluster-
corrected). These included, in the cortex, the bilateral cingulate
gyrus and planum temporale, the right pre- and postcentral gyri,
superior frontal gyrus and insular cortex and the subcallosal cortex
(Figure 4 and Table 2). In the WM, significant regions mainly
included the corpus callosum and bilateral areas of the corona
Figure 1. T2-weighted lesion probability maps in RIS and RRMS. The color overlay shows the probability of each voxel containing a lesion in
each group. The color bar denotes the probability range. Background image is the MNI standard brain. In both groups, the areas with high probability
of containing lesions were similar, mainly involving the superior and posterior regions of the corona radiata, the superior and inferior longitudinal
fascicle and the body of the corpus callosum, with similar maximum peaks of lesion occurrence (RIS: 48%, RRMS: 54%). See text for abbreviations.
doi:10.1371/journal.pone.0019452.g001
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radiata and inferior longitudinal/fronto-occipital fascicle (Figure 4
and Table 2).
Logistic regression analysis
At the univariate logistic regression analysis all MRI volumetric
variables were able to significantly separate RRMS and HC
(p ranging from 0.001 to 0.003), with NBV being able to best
separate the two groups (accuracy 88%, Nagelkerke R2= 0.84).
The MTr variables were also able to separate RRMS and HC (p
ranging from 0.001 to 0.04), lesional-MTr values of RRMS being
completely separated from the MTr values in homologous WM
areas of HC (accuracy= 100%, Nagelkerke R2= 1.0). Thus, NBV
Figure 2. Brain volumes in HC, RIS and RRMS. Box plots comparing the brain volumes of HC (left), RIS subjects (center) and RRMS patients
(right). Values are relative to NBV (left), NWMV (center) and NCV (right). Note the presence of similarly low values of brain volume in RIS subjects and
RRMS patients with respect to HC. See text for abbreviations.
doi:10.1371/journal.pone.0019452.g002
Figure 3. MTr in HC, RIS and RRMS. Box plots comparing the MTr measures of HC (left), RIS subjects (center) and RRMS patients (right). Values are
relative to whole brain-MTr (top left), lesional-MTr (top right), NAWM-MTr (bottom left) and cortical-MTr (bottom right). Note the differences between
the three groups, with generally higher MTr values in RIS subjects than in RRMS patients. See text for abbreviations.
doi:10.1371/journal.pone.0019452.g003
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and lesional-WM MTr values entered a penalized multivariate
logistic regression analysis, to estimate a multiparametric score
giving the probability for a RIS subject to be RRMS patient or
HC (Figure 5A and B). When the coefficients obtained with the
multivariate analysis were applied to the NBV and lesional-WM
MTr values of each RIS subject, 13/19 subjects showed a very
high probability (.70%; of these, 7/19 subjects had a probability
.90%) and 2/19 subjects showed a very low probability (,10%)
of being classified as RRMS (and consequently .90% probability
of being HC) (Figure 5B).
Discussion
The unanticipated MRI detection in the brain of asymptomatic
subjects of WM lesions suggestive of MS represents a frequent
incidental MRI finding, increasing with age [1], in subjects with a
history of psychiatric disorders [26] and asymptomatic first-degree
relatives of MS patients [27,28]. Improving the characterization of
these MRI findings and establishing whether or not these subjects
might be at risk of developing MS could be particularly important
as therapy with disease-modifying agents may be more beneficial
for MS patients if initiated as early as possible from disease onset
[8]. In this context, we used quantitative MR indices to obtain an
accurate assessment of the tissue damage occurring in lesions and
normal-appearing brain of a group of RIS subjects. By comparing
these subjects with demographically-matched HC and RRMS
patients, we found that i) focal brain abnormalities, as visualized
by conventional MRI, were not different in distribution and
frequency between RIS and RRMS; ii) global and tissue-specific
(i.e., WM and cortical GM) volumes were similarly lower in RIS
and RRMS than in HC; iii) changes in MTr, mostly expression of
subtle changes in tissue content and integrity [29,30,31] were, in
general, higher in RIS subjects than in RRMS patients with, at
voxelwise analysis, significant differences in clinically eloquent
regions; iv) finally, a multivariate logistic regression analysis
allowed for a better characterization of RIS, with as much as
13/19 subjects being classified as RRMS with a probability .70%
on the basis of their lesional-MTr and NBV values.
A number of recent studies have assessed conventional MRI in
subjects with RIS [3,4,5,6,32], stressing the similarity of the MRI
findings with those of patients with clinically definite MS. In our
study, both focal pathology, as expressed by T2-W and T1-W LV,
and diffuse tissue damage, as expressed by global brain volume,
were comparable in RIS subjects and RRMS patients. Moreover,
the use of LPM allowed to establish that the two groups also
showed similar probability of lesion distribution and frequency in a
given brain area. Finally, tissue-specific brain volume measure-
ments showed that RIS subjects may have, similarly to RRMS
patients, a significant amount of cortical atrophy. Overall, these
results suggest that MRI macroscopic damage is similar between
RIS and RRMS, with the impossibility of distinguishing the two
groups solely on this basis.
MT imaging, which is based on the interactions between free-
water protons and protons attached to macromolecules [33], has
proven in several studies to be superior to conventional MRI in the
detection and quantitation of subtle brain tissue changes
[13,34,35]. On conventional MRI, protons bound to macromol-
ecules do not directly contribute to the signal, but it is possible to
Figure 4. Brain voxelwise MTr comparison between RIS and RRMS. Red voxels show regions with significantly (p,0.05, cluster-corrected for
multiple comparisons) lower MTr values in RRMS than in RIS. On smaller brains at the bottom right of each image, red shows the brain regions of the
Harvard-Oxford GM atlas and DTI-based WM anatomy atlas corresponding to significant clusters. Background image is the MNI standard brain.
Significant brain regions included the superior corona radiata, the body of corpus callosum and the inferior fronto-occipital fascicle (top-left image in
coronal orientation); the paracingulate and cingulate gyri (top-right image in sagittal orientation); the inferior longitudinal fascicle, the planum
temporale and the genu of corpus callosum (bottom-left image in axial orientation), the superior corona radiata and the paracingulate and cingulate
gyri (bottom-center image in axial orientation); and the superior frontal, post- and precentral gyri (bottom-right image in axial orientation). See text
for abbreviations.
doi:10.1371/journal.pone.0019452.g004
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selectively saturate their magnetization with an appropriate off-
resonance pulse [33,36]. This is now routinely obtained from any
MR clinical scanner by acquiring two images (with the MT
saturation pulse turned on and off, respectively) that are used to
generate an MTr image in which the signal intensity of each voxel
is determined by the percent MT in that voxel. Thus, when
assessed in the brain, MTr measures provide an index of tissue
integrity at the cellular level, which in pathological conditions can
be an expression of the extent of tissue damage [33,37,38]. In such
a context, the results of the present study show that the MTr values
of RIS subjects were i) similar to those of HC and significantly
higher than those of RRMS patients in the normal-appearing
brain and ii) much less decreased in WM lesions than those of
RRMS patients. Thus, as MTr measures should be able to provide
information with considerable pathological specificity [34,35], and
MTr reductions in lesions and normal-appearing brain of MS
patients should reflect damage to cellular structures [33,37], these
data strongly suggest that subtle myelin/axonal pathology might
effectively be milder in RIS than in RRMS, despite the presence of
similar macroscopic brain tissue damage in the two groups. This
might be explained by a different degree of demyelination between
the two groups, possibly due to a more beneficial response to the
demyelinating insult occurring in the RIS subjects. Recent MS
studies combining MT imaging and histopathological findings
[30,31,39] lend support to this interpretation by showing
significantly less marked MTr decreases in remyelinated than in
demyelinated brain regions. An exceptional capability to repair
and/or to withstand the insult leading to demyelination as well as
differences in environmental and genetic loads [40] could possibly
Table 2. Brain regions of the grey and white matter where
RIS showed higher MTr than RRMS.
Cerebral region Side Z-max X Y Z
Grey matter
Subcallosal cortex M 5.73 0 12 28
Superior frontal gyrus R 5.57 16 18 60
Cingulate gyrus, anterior division L 5.48 28 14 34
R 4.59 12 14 32
L 4.50 24 16 22
L 4.43 28 214 42
Cingulate gyrus, posterior division L 5.40 26 226 28
R 3.99 14 242 4
Planum temporale L 5.38 246 228 4
R 3.76 42 230 10
Paracingulate gyrus R 4.78 4 44 22
Lingual gyrus R 4.57 14 268 34
Lateral occipital cortex L 4.14 234 268 34
Postcentral gyrus R 4.08 18 234 60
Precentral gyrus R 4.06 34 28 46
Insular cortex R 4.04 34 224 8
White matter
Superior corona radiata R 5.96 24 0 34
L 5.08 212 4 54
Inferior longitudinal fascicle L 5.52 246 228 2
L 5.05 234 278 22
Body of the corpus callosum R 5.49 4 222 24
R 4.09 2 210 26
Genu of the corpus callosum R 5.15 4 26 22
Inferior fronto-occipital fascicle R 5.09 24 38 26
R 5.04 34 246 2
Posterior corona radiata L 4.78 220 234 48
Superior cerebellar peduncle L 4.58 28 252 230
Forceps major R 4.57 10 246 12
Middle cerebellar peduncle L 4.54 216 238 240
Superior longitudinal fascicle L 4.27 236 256 32
Statistically significant regions (p,0.05, cluster-corrected for multiple
comparisons) are ordered by decreasing values of the highest local maxima
(Z-max). L = left, R = right, M=middle. MNI coordinates are expressed in mm.
doi:10.1371/journal.pone.0019452.t002
Figure 5. Logistic regression analysis: probability for RIS to be
HC or RRMS. Panel A shows the distribution of subjects according to
their NBV and lesional-WM MTr. HC are in blu, RIS subjects in red, and
RRMS patients in green. Lesional-MTr values were calculated in RIS
subjects and RRMS patients from T2-W lesional WM regions. MTr values
in the WM of HC were calculated from areas homologous to those of
the WM lesions of the RIS and RRMS. The black line separates the
subjects with a probability of being a RRMS patient below and above
50%, according to the coefficients estimated by the penalized logistic
model. The histogram of probability to be RRMS, as estimated
according to the penalized logistic model including NBV and lesional-
MTr as independent predictors, is reported in panel B. See text for
further details.
doi:10.1371/journal.pone.0019452.g005
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lead to this peculiar scenario, which is similar to that recently
shown in MS patients with benign clinical course [23] and
asymptomatic MS relatives with an MRI pattern suggestive of MS
[28].
In our study, we also compared the whole brain MTr of RIS
subjects and RRMS patients, exploiting the potential of a fully
automated voxelwise approach, a powerful tool recently used in
several studies on different neurological disorders [23,41,42,43].
Thus, we were able to ‘‘clusterize’’ those WM and GM regions
with a significantly higher MTr values in RIS than in RRMS.
Interestingly, these brain regions included, in the cortex, areas of
the sensorimotor and memory networks and, in the WM,
projection, associative, and commissural fibers such as those of
the corona radiata, superior and inferior longitudinal fascicle and
corpus callosum (see Figure 4 and Table 2). These data indicate
clinically eloquent brain regions, usually deeply involved in the
pathological substrate of MS, as those that have a minor degree of
subtle myelin/axonal pathology in RIS subjects, providing a
compelling reason for the lack of clinical manifestations existing in
these subjects. It must be stressed here that other factors such as
the already mentioned exceptional capability to repair (and
reorganize) after an insult could explain why focal demyelination
on MRI is not invariably linked to identical clinical manifestations.
At any rate, MTr has demonstrated here, as in previous studies
[23,30,38] to be a very useful and reliable MR metric to
(indirectly) assess this in vivo [44,45].
As part of the RIS subjects studied here will become MS
patients in the future, a challenge would be to be able to recognize
them in advance. Indeed, the clinical relevance of the MR findings
can be fully appreciated only with a longitudinal observation of the
single RIS subject and, in such a context, previous studies [3,5]
have found that 33% of RIS subjects have their first clinical
manifestation after 1–5 year follow-up. However, even a long-term
follow-up longitudinal study might not represent the solution to
this matter as the disease activity may remain silent for a very long
time or even a lifetime [2,46,47,48]. By contrast, in light of
providing recommendations on the strategy to follow-up subjects
who can potentially develop a disease for which an early treatment
is highly recommended, it would be critical to know whether or
not subjects with more pronounced brain MR abnormalities will
be those who will develop the disease. In recent studies [5,6], the
presence of gadolinium-enhancing lesions on post-contrast T1-W
images and asymptomatic lesions in the cervical spinal cord, were
identified as potential predictors for MRI-based DIT but not for
clinical DIT. In our study, we attempted a specific classification of
the asymptomatic subjects with RIS with the support of a logistic
regression analysis that used quantitative MR indices (i.e., NBV
and lesional-WM MTr) to derive a multiparametric score able to
provide an estimation of the probability for a RIS subject to be
RRMS or HC. On this basis, we found that 13/19 RIS showed a
.70% probability of being RRMS. Intriguingly, they included all
the 10 subjects who showed abnormal CSF (6 of them with .90%
probability of being RRMS), 9/10 subjects who showed a DIT on
the new conventional MRI examination and 6/7 RIS subjects
with cervical spinal cord lesions, suggesting that this type of
analysis, by providing a more specific characterization of the RIS
subjects, could potentially narrow down the cohort with a high risk
of progression to MS.
In conclusion, the use of quantitative MR markers sensitive to
both macroscopic and microscopic pathology provided indications
that, while focal and diffuse macroscopic brain damage is by and
large similar between RIS and RRMS (and significantly different
from HC), the subtle myelin/axonal damage as detected by MTr
can be much milder in RIS subjects than in RRMS patients. The
evidence that this milder tissue damage occurs in brain regions
that are clinically relevant to MS might provide a plausible
biological explanation for the lack of clinical manifestations
existing in RIS subjects. Finally, we attempted an estimation here
of the RIS subjects who were closer to RRMS on the basis of their
quantitative MR metrics, providing a characterization of RIS
subjects that fully matched with the occurrence of abnormal
immunological pattern in these subjects. The clinical relevance of
the proposed new approach for a more specific characterization of
subjects with RIS needs to be confirmed in future prospective
studies able to elucidate whether these and other biomarkers could
be successfully used to address the management of subjects with
this new pre-clinical condition.
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